5-bromo-2-(trifluoromethyl)-1,4-dihydropyridin-4-one, 95%, 1g

5-cyclopropyl-3-(thiophen-2-yl)-1H-pyrazole, 95.0%, 500mg

Columna HPLC NUCLEODUR® NH2 5 µm, 250 mm, 4,6 mm, 1 Pieza(s)

Ethyl quinazoline-2-carboxylate, 95+%, 250mg

tert-Butyl 4-chloropicolinate, 95.0%, 5g

18-amino-1-(diazyn-1-ium-1-yl)-4,7,10,13,16-pentaoxa-1-azaoctadecan-1-ide, 97%, 5g

Imidazolidinyl Urea>90.0%(N)250g

1-[(5-Chloro-2-thienyl)sulfonyl]piperidine-3-carboxylic acid, 95.0%, 250mg

3-Fluoro-2-methoxyaniline, 97.0%, 1g

2-Amino-5-chloro-3-iodopyridine>98.0%(GC)(T)1g

(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(2,5-dichlorophenyl)prop-2-en-1-one, 95.0%, 2g

2-Cyano-N-cyclopropyl-N-((2-fluoro-4-iodophenyl)carbamoyl)acetamide, 98%, 1g

5-cyclopropyl-3-(thiophen-2-yl)-1H-pyrazole, 95.0%, 250mg